Oryzon Genomics Management
Management criteria checks 2/4
Oryzon Genomics' CEO is Carlos Manuel Arjol, appointed in Jan 2000, has a tenure of 24.25 years. directly owns 5.04% of the company’s shares, worth €5.75M. The average tenure of the management team and the board of directors is 3.5 years and 8.4 years respectively.
Key information
Carlos Manuel Arjol
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 24.3yrs |
| CEO ownership | 5.0% |
| Management average tenure | 3.5yrs |
| Board average tenure | 8.4yrs |
Recent management updates
Recent updates
Oryzon Genomics S.A. (BME:ORY) Screens Well But There Might Be A Catch
Jun 09
Is Oryzon Genomics (BME:ORY) Using Too Much Debt?
Apr 04Industry Analysts Just Made A Dazzling Upgrade To Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts
Jul 24Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?
May 01Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?
Feb 26If You Had Bought Oryzon Genomics (BME:ORY) Shares A Year Ago You'd Have Earned 18% Returns
Jan 04
CEO
Carlos Manuel Arjol
24.3yrs
Tenure
US$62,992
Compensation
Dr. Carlos Manuel Buesa Arjol Co-Founded Oryzon Genomics S.A. in 2000 and has been its Chairman and Chief Executive Officer since 2001 and serves as its President and served as its Member of Financial Advi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 24.3yrs | US$62.99k | 5.04% $ 5.8m | |
| Director of Operations | 3.8yrs | no data | no data | |
| Chief Scientific Officer | 3.3yrs | no data | no data | |
| Head of Internal Audit & Compliance | no data | no data | no data | |
| Chief Business Development Officer | no data | no data | no data | |
| Chief Intellectual Property Officer | 12.6yrs | no data | no data | |
| Chief Medical Officer of CNS | 3.3yrs | no data | no data | |
| Chief of Clinical Operations | 6.5yrs | no data | no data | |
| Senior Vice President of Clinical Development & Global Medical Affairs | 2.3yrs | no data | no data | |
| Global Chief Medical Officer | 2.1yrs | no data | no data | |
| Secretary | no data | no data | no data |
3.5yrs
Average Tenure
Experienced Management: ORY's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 23.3yrs | US$62.99k | 5.04% $ 5.8m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 8.4yrs | US$7.60k | no data | |
| Member of Scientific Advisory Board | 6.2yrs | no data | no data | |
| Lead Independent Director | 3.9yrs | no data | no data | |
| Director | 22.2yrs | US$6.52k | 2.16% $ 2.5m | |
| VP of the Board & President of Scientific Advisory Board | 24.3yrs | US$62.99k | 4.33% $ 4.9m | |
| Independent Director | 8.4yrs | US$7.60k | 0.032% $ 36.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 8.4yrs | US$7.60k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
8.4yrs
Average Tenure
65yo
Average Age
Experienced Board: ORY's board of directors are considered experienced (8.4 years average tenure).